The authors reply:

Affiliations

¹ Sanum Polska, Szczecin, Poland.
² 1] Department of Internal Medicine, Baylor Scott and White Health, Temple, Texas, USA [2] Texas A&M Health Science Center College of Medicine, Temple, Texas, USA.

Free article

Comment

Igor Łoniewski et al. Kidney Int. 2014 Nov.

Free article

. 2014 Nov;86(5):1056-7.

doi: 10.1038/ki.2014.192.

¹ Sanum Polska, Szczecin, Poland.
² 1] Department of Internal Medicine, Baylor Scott and White Health, Temple, Texas, USA [2] Texas A&M Health Science Center College of Medicine, Temple, Texas, USA.

No abstract available

Comment on

Bicarbonate therapy for prevention of chronic kidney disease progression.
Łoniewski I, Wesson DE. Łoniewski I, et al. Kidney Int. 2014 Mar;85(3):529-35. doi: 10.1038/ki.2013.401. Epub 2013 Oct 9. Kidney Int. 2014. PMID: 24107852 Review.
Bicarbonate therapy, phosphate binders, and risk for vascular calcification.
Fernandez-Fernandez B, Martin-Cleary C, Ortiz A. Fernandez-Fernandez B, et al. Kidney Int. 2014 Nov;86(5):1056. doi: 10.1038/ki.2014.191. Kidney Int. 2014. PMID: 25360495 No abstract available.